The Blogs: Nov 22, 2011

2-to-1 Majority Envisions Personalized Medicine Approach to Autism, ASDs

Alex Philippidis

Researchers will someday develop a successful personalized medicine approach to treating autism and autism spectrum disorders (ASDs), according to a nearly two-to-one majority among those who voted on GEN's poll (click here for details). By a 55.4% to a 28.5% margin, with 16.2% undecided, respondents expressed confidence in the ability of researchers to tackle this very complex disease: Autism and ASDs are linked to different genes in different people, with multiple genes possibly involved. Those genetic factors, in turn, may interact with as yet unidentified environmental factors. GEN surveyed readers four months after a July article in Archives of General Psychiatry concluded that environmental factors account for about 62% of autism risk vs. 38% from genetics.

Related content

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.

Subscribe

e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.

 

All fields are required

Email
  Confirm Email
  First Name
  Last Name
  Organization
  E-Alert Format
 
 
  Sign Up

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

GENpoll

Potential of Synthetic Biology

Do you think synthetic biology has the ability to offer solutions for problems related to health and the environment?

Suggest a Poll